News | Radiation Therapy | September 27, 2017

MedLever Platform to enable interoperability for patient setup and imaging process with MR-guided proton treatment delivery

MedLever and Hong Kong Sanatorium Partner to Streamline Proton Therapy Workflow

September 27, 2017 — MedLever Inc. recently announced the launch of a comprehensive agreement with the Hong Kong Sanatorium & Hospital (HKSH) to use the MedLever Platform to enable interoperability and streamline workflow for proton therapy delivery. MedLever and HKSH are working together to develop the information backbone to support the magnetic resonance (MR)-guided proton therapy solution being developed at HKSH. Additionally, MedLever will support the information management needs for conventional patient setup incorporating MR imaging. The solution will be first deployed in the conventional therapy department to enable simplified workflow, effective connectivity and data exchange among multiple systems.

The novel setup room methodology developed by the HKSH and supported by the MedLever Platform improves efficiency and patient throughput. By joining forces, MedLever and the HKSH are building an infrastructure solution to enable interoperability among disparate imaging and therapy modalities including MR, conventional X-ray, computed tomography (CT) and photon/proton treatment delivery systems from several vendors.

Image-guided patient positioning in the setup room using the MedLever Platform improves patient throughput significantly and permits the flexible use of different imaging modalities including MRI. Ben Yu, Ph.D., head, medical physics and research at HKSH stated that “one of the keys of success is the capability to transfer data between setup room, gantry room and the treatment planning system. We are delighted to have MedLever working with us on this project and making MR-guided radiation therapy using the setup room possible.”

“We wanted a vendor that had experience with Mosaiq and demonstrated development flexibility to adapt to our changing needs here at HKSH,” added George Chiu, M.D., head, radiotherapy. “MedLever has demonstrated the willingness to listen and the flexibility to change throughout our pilot project. We look forward to further collaborations between MedLever and HKSH in enhancing our patient care.”

For more information: www.medlever.com


Related Content

News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
News | Prostate Cancer

May 2, 2024 — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving the ...

Time May 02, 2024
arrow
News | FDA

April 29, 2024 — The U.S. Food and Drug Administration (FDA) announced Elekta Instrument AB is recalling Disposable ...

Time April 29, 2024
arrow
News | Radiation Dose Management

April 25, 2024 — BIOTRONIK, a leading global medical technology company specializing in innovative cardiovascular and ...

Time April 25, 2024
arrow
News | Artificial Intelligence

March 28, 2024 — As artificial intelligence (AI) makes its way into cancer care – and into discussions between ...

Time March 28, 2024
arrow
News | Prostate Cancer

March 27, 2024 — A minimally invasive treatment using MRI and transurethral ultrasound instead of surgery or radiation ...

Time March 27, 2024
arrow
Videos | Radiation Oncology

In the conclusion of this 3-part video series on recent advancements in diagnostic radiology, current editorial advisory ...

Time March 19, 2024
arrow
News | Breast Imaging

March 18, 2024 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time March 18, 2024
arrow
Feature | Radiation Oncology | By Christine Book

Appreciating the considerable advances in the clinical application of artificial intelligence (AI) within healthcare ...

Time March 06, 2024
arrow
News | FDA

March 1, 2024 — Varian, a Siemens Healthineers company, announced that it has received 510(k) clearance from the U.S ...

Time March 01, 2024
arrow
Subscribe Now